董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Marc Seelenfreund | 男 | Director | 59 | 58.89万美元 | 58.82 | 2026-07-01 |
| Thomas Tarala | 男 | Independent Director | 60 | 1.22万美元 | 未持股 | 2026-07-01 |
| Aitan Zacharin | 男 | Chief Executive Officer and Director | 42 | 18.70万美元 | 162.65 | 2026-07-01 |
| Mordechai Stenge | 男 | Independent Director | 47 | 1.22万美元 | 未持股 | 2026-07-01 |
| Luisa Ingargiola | 女 | Independent Director | 58 | 1.22万美元 | 未持股 | 2026-07-01 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Aitan Zacharin | 男 | Chief Executive Officer and Director | 42 | 18.70万美元 | 162.65 | 2026-07-01 |
| Arie Goor | 男 | Chief Financial Officer | 43 | 未披露 | 未持股 | 2026-07-01 |
董事简历
中英对照 | 中文 | 英文- Marc Seelenfreund
-
Marc Seelenfreund自2025年12月29日起担任PTT的创始人和董事。根据公司与Seelenfreund先生控制的实体BSD Capital Ltd.之间的咨询协议，Seelenfreund先生自2026年1月1日起担任首席执行官，根据该协议，他将全身心投入为公司提供行政服务。Seelenfreund先生此前自2015年7月起担任Siyata Mobile Inc.（现称为Core AI Holdings，Inc.）的创始人兼首席执行官。2004年8月至2015年7月，他担任Accel Telecom Inc.的首席执行官，该公司是以色列电信市场先进电信设备的主要进口商和集成商。Seelenfreund先生在Bar Ilan大学获得法学学位，并且是Ono学术学院的主席。
Marc Seelenfreund is the founder and director of PTT since December 29, 2025. Mr. Seelenfreund has been chief executive officer since January 1, 2026, pursuant to a consulting agreement between the Company and BSD Capital Ltd., an entity controlled by Mr. Seelenfreund, under which he devotes his full time attention and capacity to providing executive sercies to the Company. Mr. Seelenfreund previously served as Founder and Chief Executive Officer of Siyata Mobile Inc. (now known as Core AI Holdings, Inc.) since July 2015. From August 2004 to July 2015, he served as Chief Executive Officer of Accel Telecom Inc., a key importer and integrator of advanced telecom equipment into the Israeli telecom market. Mr. Seelenfreund received a law degree from Bar Ilan University and is Chairman of Ono Academic College. - Marc Seelenfreund自2025年12月29日起担任PTT的创始人和董事。根据公司与Seelenfreund先生控制的实体BSD Capital Ltd.之间的咨询协议，Seelenfreund先生自2026年1月1日起担任首席执行官，根据该协议，他将全身心投入为公司提供行政服务。Seelenfreund先生此前自2015年7月起担任Siyata Mobile Inc.（现称为Core AI Holdings，Inc.）的创始人兼首席执行官。2004年8月至2015年7月，他担任Accel Telecom Inc.的首席执行官，该公司是以色列电信市场先进电信设备的主要进口商和集成商。Seelenfreund先生在Bar Ilan大学获得法学学位，并且是Ono学术学院的主席。
- Marc Seelenfreund is the founder and director of PTT since December 29, 2025. Mr. Seelenfreund has been chief executive officer since January 1, 2026, pursuant to a consulting agreement between the Company and BSD Capital Ltd., an entity controlled by Mr. Seelenfreund, under which he devotes his full time attention and capacity to providing executive sercies to the Company. Mr. Seelenfreund previously served as Founder and Chief Executive Officer of Siyata Mobile Inc. (now known as Core AI Holdings, Inc.) since July 2015. From August 2004 to July 2015, he served as Chief Executive Officer of Accel Telecom Inc., a key importer and integrator of advanced telecom equipment into the Israeli telecom market. Mr. Seelenfreund received a law degree from Bar Ilan University and is Chairman of Ono Academic College.
- Thomas Tarala
-
Thomas Tarala在纽约、伦敦和香港拥有30年的国际企业融资经验，包括担任两家国际领先律师事务所的合伙人，以及中国最大的私营企业集团之一的国际业务总法律顾问。作为Baker McKenzie在2022年3月至2024年5月期间的合伙人，以及职业生涯早期的Hogan Lovells，Tarala先生曾在香港领导美国证券业务，就股权和债务交易提供咨询，以及涉及在纳斯达克上市公司的跨境合资企业。他特别专注于科技领域，曾为中国大陆、中国香港、新加坡、印度尼西亚和泰国的公司和投资银行提供代理服务，包括参与该地区的获奖交易。作为一家大型企业集团的海外总部海航集团（国际）有限公司的总法律顾问，从2017年7月到2022年3月，塔拉拉先生与业务团队密切合作，处理范围广泛的企业和金融交易，包括数十亿美元的收购和剥离家喻户晓的公司、出售航空公司，以及从纽约和伦敦的摩天大楼到全球科技公司的一系列投资，以及在各自领域全球排名第一的众多公司。塔拉拉以优异成绩和Phi Beta Kappa毕业于乔治敦大学，获得外交服务理学学士学位，并拥有弗吉尼亚大学法学院的法学博士学位。他会说英语、法语、西班牙语、普通话，有资格在纽约州、康涅狄格州、佛罗里达州、英格兰和威尔士以及香港执业。
Thomas Tarala has 30 years of international corporate finance experience in New York, London, and Hong Kong, including as a partner at two leading international law firms and as General Counsel for the international operations of one of the largest private conglomerates in China. As a partner of Baker McKenzie from March 2022 to May 2024 and Hogan Lovells earlier in his career, Mr. Tarala has led U.S. securities practices in Hong Kong, advising on equity and debt transactions, as well as cross border joint ventures involving companies listed on Nasdaq. With a particular focus on the technology sector, he has acted for companies and investment banks in Mainland China, Hong Kong, Singapore, Indonesia, and Thailand, including on award winning transactions in the region.As General Counsel of HNA Group (International) Company Limited, the overseas headquarters of a large conglomerate, from July 2017 to March 2022, Mr. Tarala worked closely with the business teams on a wide range of corporate and finance transactions, including multi billion dollar acquisitions and divestments of household name companies, the sale of airlines, and a range of investments ranging from New York and London skyscrapers to global technology companies, as well as numerous companies that were number one globally in their respective fields.Mr. Tarala graduated magna cum laude and Phi Beta Kappa from Georgetown University with a Bachelor of Science degree in Foreign Service and holds a Juris Doctor degree from the University of Virginia School of Law. He speaks English, French, Spanish, and Mandarin and is qualified to practice law in New York, Connecticut, Florida, England and Wales, and Hong Kong. - Thomas Tarala在纽约、伦敦和香港拥有30年的国际企业融资经验，包括担任两家国际领先律师事务所的合伙人，以及中国最大的私营企业集团之一的国际业务总法律顾问。作为Baker McKenzie在2022年3月至2024年5月期间的合伙人，以及职业生涯早期的Hogan Lovells，Tarala先生曾在香港领导美国证券业务，就股权和债务交易提供咨询，以及涉及在纳斯达克上市公司的跨境合资企业。他特别专注于科技领域，曾为中国大陆、中国香港、新加坡、印度尼西亚和泰国的公司和投资银行提供代理服务，包括参与该地区的获奖交易。作为一家大型企业集团的海外总部海航集团（国际）有限公司的总法律顾问，从2017年7月到2022年3月，塔拉拉先生与业务团队密切合作，处理范围广泛的企业和金融交易，包括数十亿美元的收购和剥离家喻户晓的公司、出售航空公司，以及从纽约和伦敦的摩天大楼到全球科技公司的一系列投资，以及在各自领域全球排名第一的众多公司。塔拉拉以优异成绩和Phi Beta Kappa毕业于乔治敦大学，获得外交服务理学学士学位，并拥有弗吉尼亚大学法学院的法学博士学位。他会说英语、法语、西班牙语、普通话，有资格在纽约州、康涅狄格州、佛罗里达州、英格兰和威尔士以及香港执业。
- Thomas Tarala has 30 years of international corporate finance experience in New York, London, and Hong Kong, including as a partner at two leading international law firms and as General Counsel for the international operations of one of the largest private conglomerates in China. As a partner of Baker McKenzie from March 2022 to May 2024 and Hogan Lovells earlier in his career, Mr. Tarala has led U.S. securities practices in Hong Kong, advising on equity and debt transactions, as well as cross border joint ventures involving companies listed on Nasdaq. With a particular focus on the technology sector, he has acted for companies and investment banks in Mainland China, Hong Kong, Singapore, Indonesia, and Thailand, including on award winning transactions in the region.As General Counsel of HNA Group (International) Company Limited, the overseas headquarters of a large conglomerate, from July 2017 to March 2022, Mr. Tarala worked closely with the business teams on a wide range of corporate and finance transactions, including multi billion dollar acquisitions and divestments of household name companies, the sale of airlines, and a range of investments ranging from New York and London skyscrapers to global technology companies, as well as numerous companies that were number one globally in their respective fields.Mr. Tarala graduated magna cum laude and Phi Beta Kappa from Georgetown University with a Bachelor of Science degree in Foreign Service and holds a Juris Doctor degree from the University of Virginia School of Law. He speaks English, French, Spanish, and Mandarin and is qualified to practice law in New York, Connecticut, Florida, England and Wales, and Hong Kong.
- Aitan Zacharin
-
Aitan Zacharin自2025年10月3日完成合并以来一直担任首席执行官和董事。自2024年5月成立以来，他一直担任Core Gaming的首席执行官和董事。Zacharin先生是一位经验丰富的高管，在建立和管理生物制药、医疗保健、技术和消费品（“CPG”）领域的业务方面拥有广泛的知识。Zacharin先生创立并经营了多家公司，从种子阶段到在美国证券交易所上市，集体估值超过15亿美元。
Aitan Zacharin has served as Chief Executive Officer and a director since completion of the Merger on October 3, 2025. He has served as Chief Executive Officer and a director of Core Gaming since its formation in May 2024. Mr. Zacharin is a seasoned executive with broad knowledge in building and managing businesses across the biopharmaceutical, healthcare, technology, and consumer products ("CPG") sectors. Mr. Zacharin has founded and operated multiple companies, from seed stage to listing on U.S. stock exchanges, with collective valuations of over $1.5 billion. - Aitan Zacharin自2025年10月3日完成合并以来一直担任首席执行官和董事。自2024年5月成立以来，他一直担任Core Gaming的首席执行官和董事。Zacharin先生是一位经验丰富的高管，在建立和管理生物制药、医疗保健、技术和消费品（“CPG”）领域的业务方面拥有广泛的知识。Zacharin先生创立并经营了多家公司，从种子阶段到在美国证券交易所上市，集体估值超过15亿美元。
- Aitan Zacharin has served as Chief Executive Officer and a director since completion of the Merger on October 3, 2025. He has served as Chief Executive Officer and a director of Core Gaming since its formation in May 2024. Mr. Zacharin is a seasoned executive with broad knowledge in building and managing businesses across the biopharmaceutical, healthcare, technology, and consumer products ("CPG") sectors. Mr. Zacharin has founded and operated multiple companies, from seed stage to listing on U.S. stock exchanges, with collective valuations of over $1.5 billion.
- Mordechai Stenge
-
合并完成后，Mordechai Stenge于2025年10月3日加入董事会。他是联合创始人，自2021年10月起担任技术通信平台TextGrid，Ltd.的首席财务和首席运营官，负责监督公司的战略运营、成本结构优化、财务建模以及支持其增长的基础设施扩展。自2017年5月以来，Stenge先生还担任Patient Communicator Ltd.的首席财务和首席运营官，该公司提供患者参与软件，帮助牙科和医疗实践显着减少未出现、增加收入并优化办公效率。他还曾于2023年1月至2024年1月担任Greater Cannabis Company，Inc.的首席运营官。在此之前，Stenge先生于2020年1月至2022年2月期间担任Cantek Global，Ltd.的首席运营官，该公司进口、开发、储存、包装和分销医用大麻产品，负责管理IT投资的财务资源分配和战略规划，并确保技术运营的高效资本部署。
Mordechai Stenge joined the board of directors on October 3, 2025, upon completion of the Merger. He is a co-founder and since October 2021 has served as the Chief Financial and Chief Operating Officer of TextGrid, Ltd., a technology communications platform, where he oversees the company's strategic operations, cost structure optimization, financial modeling, and infrastructure scaling to support its growth. Mr. Stenge has also served as Chief Financial and Chief Operating Officer at Patient Communicator Ltd., which provides patient engagement software that helps dental and medical practices dramatically reduce no-shows, increase revenues, and optimize office efficiency, since May 2017. He also served as Chief Operating Officer of The Greater Cannabis Company, Inc., from January 2023 to January 2024. Prior to that Mr. Stenge served as Chief Operating Officer of Cantek Global, Ltd., which imports, develops, stores, packages and distributes medical cannabis products, from January 2020 to February 2022, where he managed financial resource allocation and strategic planning for IT investments and ensured the efficient capital deployment for technology operations. - 合并完成后，Mordechai Stenge于2025年10月3日加入董事会。他是联合创始人，自2021年10月起担任技术通信平台TextGrid，Ltd.的首席财务和首席运营官，负责监督公司的战略运营、成本结构优化、财务建模以及支持其增长的基础设施扩展。自2017年5月以来，Stenge先生还担任Patient Communicator Ltd.的首席财务和首席运营官，该公司提供患者参与软件，帮助牙科和医疗实践显着减少未出现、增加收入并优化办公效率。他还曾于2023年1月至2024年1月担任Greater Cannabis Company，Inc.的首席运营官。在此之前，Stenge先生于2020年1月至2022年2月期间担任Cantek Global，Ltd.的首席运营官，该公司进口、开发、储存、包装和分销医用大麻产品，负责管理IT投资的财务资源分配和战略规划，并确保技术运营的高效资本部署。
- Mordechai Stenge joined the board of directors on October 3, 2025, upon completion of the Merger. He is a co-founder and since October 2021 has served as the Chief Financial and Chief Operating Officer of TextGrid, Ltd., a technology communications platform, where he oversees the company's strategic operations, cost structure optimization, financial modeling, and infrastructure scaling to support its growth. Mr. Stenge has also served as Chief Financial and Chief Operating Officer at Patient Communicator Ltd., which provides patient engagement software that helps dental and medical practices dramatically reduce no-shows, increase revenues, and optimize office efficiency, since May 2017. He also served as Chief Operating Officer of The Greater Cannabis Company, Inc., from January 2023 to January 2024. Prior to that Mr. Stenge served as Chief Operating Officer of Cantek Global, Ltd., which imports, develops, stores, packages and distributes medical cannabis products, from January 2020 to February 2022, where he managed financial resource allocation and strategic planning for IT investments and ensured the efficient capital deployment for technology operations.
- Luisa Ingargiola
-
Luisa Ingargiola自2017年2月起担任Avalon GloboCare Corp.（纳斯达克：ALTB）的首席财务官。Ingargiola女士自2020年12月起担任Vision Marine Technologies Inc.（纳斯达克：VMAR）董事兼审计委员会主席，自2018年4月起担任BioCorRx Inc.（OTCQB：BICX）董事兼审计委员会主席，自2025年2月起担任Fion Fuel Green PLC（纳斯达克：HTOO）董事，并在该公司董事会担任审计委员会（主席）、提名委员会及薪酬委员会成员，且自2021年6月起担任Dragonfly Energy Holdings Corp.（纳斯达克：DFLI）董事。此外，Ingargiola女士还曾于2018年5月至2022年11月担任AgEagle Aerial Systems Inc.（NYSE American：UAVS）董事兼审计委员会主席，于2020年12月至2021年12月担任Siyata Mobile董事兼审计委员会主席，并曾于2024年3月至2025年6月担任Xos, Inc.董事，于2018年3月至2024年3月（该公司被Xos收购期间）担任ElectraMeccanica Vehicles Corp.董事，以及于2020年11月至2023年2月担任Progress Acquisition Corp.董事。Ingargiola女士毕业于波士顿大学，获工商管理学士学位，主修金融专业，并拥有South Florida大学的健康管理硕士学位。
Luisa Ingargiola has served as Avalon Globocare Corp's Chief Strategy Officer since June 5, 2026. Ms Ingargiola served as Avalon Globocare Corp's Chief Financial Officer from February 21, 2017 to June 3, 2026. Ms. Ingargiola has significant experience serving as Chief Financial Officer or Audit Chair for multiple Nasdaq and New York Stock Exchange companies. She currently serves as Director and Audit Chair for several public companies, including Fusion Fuels (NASDAQ:HTOO), Dragonfly Energy (DFLI) and Vision Marine (VMAR), among others. She also sits on the Board of several Special Purpose Acquisition Corporations. From 2007 through 2016, Ms. Ingargiola served as the Chief Financial Officer and then a member of the board of directors at MagneGas Corporation (Nasdaq: MNGA). Prior to 2007, Ms. Ingargiola held various roles as Budget Director and Investment Analyst in several private companies. Ms. Ingargiola graduated in 1989 from Boston University with a Bachelor's degree in Business Administration and a concentration in Finance. In 1996, she received her MBA in Health Administration from the University of South Florida. - Luisa Ingargiola自2017年2月起担任Avalon GloboCare Corp.（纳斯达克：ALTB）的首席财务官。Ingargiola女士自2020年12月起担任Vision Marine Technologies Inc.（纳斯达克：VMAR）董事兼审计委员会主席，自2018年4月起担任BioCorRx Inc.（OTCQB：BICX）董事兼审计委员会主席，自2025年2月起担任Fion Fuel Green PLC（纳斯达克：HTOO）董事，并在该公司董事会担任审计委员会（主席）、提名委员会及薪酬委员会成员，且自2021年6月起担任Dragonfly Energy Holdings Corp.（纳斯达克：DFLI）董事。此外，Ingargiola女士还曾于2018年5月至2022年11月担任AgEagle Aerial Systems Inc.（NYSE American：UAVS）董事兼审计委员会主席，于2020年12月至2021年12月担任Siyata Mobile董事兼审计委员会主席，并曾于2024年3月至2025年6月担任Xos, Inc.董事，于2018年3月至2024年3月（该公司被Xos收购期间）担任ElectraMeccanica Vehicles Corp.董事，以及于2020年11月至2023年2月担任Progress Acquisition Corp.董事。Ingargiola女士毕业于波士顿大学，获工商管理学士学位，主修金融专业，并拥有South Florida大学的健康管理硕士学位。
- Luisa Ingargiola has served as Avalon Globocare Corp's Chief Strategy Officer since June 5, 2026. Ms Ingargiola served as Avalon Globocare Corp's Chief Financial Officer from February 21, 2017 to June 3, 2026. Ms. Ingargiola has significant experience serving as Chief Financial Officer or Audit Chair for multiple Nasdaq and New York Stock Exchange companies. She currently serves as Director and Audit Chair for several public companies, including Fusion Fuels (NASDAQ:HTOO), Dragonfly Energy (DFLI) and Vision Marine (VMAR), among others. She also sits on the Board of several Special Purpose Acquisition Corporations. From 2007 through 2016, Ms. Ingargiola served as the Chief Financial Officer and then a member of the board of directors at MagneGas Corporation (Nasdaq: MNGA). Prior to 2007, Ms. Ingargiola held various roles as Budget Director and Investment Analyst in several private companies. Ms. Ingargiola graduated in 1989 from Boston University with a Bachelor's degree in Business Administration and a concentration in Finance. In 1996, she received her MBA in Health Administration from the University of South Florida.
高管简历
中英对照 | 中文 | 英文- Aitan Zacharin
Aitan Zacharin自2025年10月3日完成合并以来一直担任首席执行官和董事。自2024年5月成立以来，他一直担任Core Gaming的首席执行官和董事。Zacharin先生是一位经验丰富的高管，在建立和管理生物制药、医疗保健、技术和消费品（“CPG”）领域的业务方面拥有广泛的知识。Zacharin先生创立并经营了多家公司，从种子阶段到在美国证券交易所上市，集体估值超过15亿美元。
Aitan Zacharin has served as Chief Executive Officer and a director since completion of the Merger on October 3, 2025. He has served as Chief Executive Officer and a director of Core Gaming since its formation in May 2024. Mr. Zacharin is a seasoned executive with broad knowledge in building and managing businesses across the biopharmaceutical, healthcare, technology, and consumer products ("CPG") sectors. Mr. Zacharin has founded and operated multiple companies, from seed stage to listing on U.S. stock exchanges, with collective valuations of over $1.5 billion.- Aitan Zacharin自2025年10月3日完成合并以来一直担任首席执行官和董事。自2024年5月成立以来，他一直担任Core Gaming的首席执行官和董事。Zacharin先生是一位经验丰富的高管，在建立和管理生物制药、医疗保健、技术和消费品（“CPG”）领域的业务方面拥有广泛的知识。Zacharin先生创立并经营了多家公司，从种子阶段到在美国证券交易所上市，集体估值超过15亿美元。
- Aitan Zacharin has served as Chief Executive Officer and a director since completion of the Merger on October 3, 2025. He has served as Chief Executive Officer and a director of Core Gaming since its formation in May 2024. Mr. Zacharin is a seasoned executive with broad knowledge in building and managing businesses across the biopharmaceutical, healthcare, technology, and consumer products ("CPG") sectors. Mr. Zacharin has founded and operated multiple companies, from seed stage to listing on U.S. stock exchanges, with collective valuations of over $1.5 billion.
- Arie Goor
Arie Goor，于2022年10月至2026年1月期间担任再生医学公司Regentis Biomaterials（NYSE：RGNT）的首席财务官，于2023年6月至2026年5月期间担任Revium RX（Revium Recovery）的首席财务官。在其整个职业生涯中，他成功地领导了全球主要交易所的无数首次公开募股和跨境资本市场交易，包括纳斯达克、澳大利亚证券交易所（ASX）、多伦多证券交易所创业板（TSXV）、特拉维夫证券交易所（TASE）。
Arie Goor,served as Chief Financial Officer of Regentis Biomaterials (NYSE: RGNT), a regenerative medicine company, from October 2022 until January 2026, and Chief Financial Officer of Revium Rx (Revium Recovery) from June 2023 until May 2026. Throughout his career, he has successfully led numerous initial public offerings and cross-border capital markets transactions on major global exchanges, including NASDAQ, the Australian Securities Exchange (ASX), the TSX Venture Exchange (TSXV), and the Tel Aviv Stock Exchange (TASE).- Arie Goor，于2022年10月至2026年1月期间担任再生医学公司Regentis Biomaterials（NYSE：RGNT）的首席财务官，于2023年6月至2026年5月期间担任Revium RX（Revium Recovery）的首席财务官。在其整个职业生涯中，他成功地领导了全球主要交易所的无数首次公开募股和跨境资本市场交易，包括纳斯达克、澳大利亚证券交易所（ASX）、多伦多证券交易所创业板（TSXV）、特拉维夫证券交易所（TASE）。
- Arie Goor,served as Chief Financial Officer of Regentis Biomaterials (NYSE: RGNT), a regenerative medicine company, from October 2022 until January 2026, and Chief Financial Officer of Revium Rx (Revium Recovery) from June 2023 until May 2026. Throughout his career, he has successfully led numerous initial public offerings and cross-border capital markets transactions on major global exchanges, including NASDAQ, the Australian Securities Exchange (ASX), the TSX Venture Exchange (TSXV), and the Tel Aviv Stock Exchange (TASE).